Intelgenx Corp.
🇨🇦Canada
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Safety, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease
Phase 2
Completed
- Conditions
- Alzheimer Disease
- Interventions
- Other: Placebo buccal film
- First Posted Date
- 2018-01-18
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- IntelGenx Corp.
- Target Recruit Count
- 52
- Registration Number
- NCT03402503
- Locations
- 🇨🇦
Vancouver Island Health Authority, Victoria, British Columbia, Canada
🇨🇦Centricity Research (formerly True North Clinical Research), New Minas, Nova Scotia, Canada
🇨🇦Bruyère Research Institute, Ottawa, Ontario, Canada
News
No news found